Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter's Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Growing number of Private Diagnostic Centres
4.1.2 Increasing Government expenditures on Healthcare
4.1.3 Raising incidence of chronic lifestyles and infectious diseases
4.1.4 Increasing adoption of point-of-care testing
4.2 Restraints
4.2.1 Raising Healthcare costs
4.2.2 Stringent Regularity Policies
4.3 Opportunities
4.3.1 Growing incidence of companion diagnostics.
4.3.2 Convergence of New Technologies.
4.4 Challenges
4.4.1 Stringent regularity framework
4.4.2 Barriers to use of these diagnostic tests
Chapter 5 Asia-Pacific In-Vitro Diagnostics Market – By Product & Service
5.1 Instruments
5.2 Reagents & Kits
5.3 Services
5.4 Data Management Software
5.5 Others
Chapter 6 Asia-Pacific In-Vitro Diagnostics Market – By Technology
6.1 Immunodiagnostics
6.1.1 Rapid Test
6.1.2 Western Bolt
6.1.3 Radioimmunoassay
6.1.4 Others
6.2 Clinical Chemistry
6.2.1 Liver Panel
6.2.2 Electrolyte Panel
6.2.3 Basic Metabolic Panel
6.2.4 Thyroid Functional Panel
6.2.5 Others
6.3 Molecular Diagnostics
6.3.1 Hybridization
6.3.2 Microarray
6.3.3 DNA Sequencing & Next Generation Sequencing
6.3.4 Other Molecular Diagnostics Technologies
6.4 Haematology
6.5 Clinical Microbiology
6.6 Coagulation & Hemostasis
6.7 Others
Chapter 7 Asia-Pacific In-Vitro Diagnostics Market – By Application
7.1 Cardiology
7.2 Infectious Diseases
7.3 Diabetics
7.4 Oncology/Cancer
7.5 Autoimmune Diseases
7.6 HIV/AIDS
7.7 Drug Testing
7.8 Others
Chapter 8 Asia-Pacific In-Vitro Diagnostics Market – By End-User
8.1 Hospitals
8.2 Point of Care Testing
8.3 Laboratories
8.4 Academic Institution
8.5 Patient Self Testing
8.6 Other End-User’s
Chapter 9 Asia-Pacific In-Vitro Diagnostics Market - By Geography
9.1 Introduction
9.2 APAC
9.2.1 China
9.2.2 Japan
9.2.3 India
9.2.4 South Korea
9.2.5 Australia & New Zealand
9.2.6 Rest of APAC
Chapter 10 Asia-Pacific In-Vitro Diagnostics Market - Company Profiles
10.1 Abbott Laboratories, INC
10.2 Beckton, Dickinson and Company
10.3 Biomerieux SA
10.4 Bio-Rad Laboratories, INC
10.5 Danaher Corporation
10.6 Roche Diagnostics
10.7 Alere, INC
10.8 Bayer AG
10.9 Arkray
10.10 Grifols
10.11 Hologic
10.12 Illumina
10.13 Luminex
10.14 Quest Diagnostics
Chapter 11 Asia-Pacific In-Vitro Diagnostics Market - Competitive Landscape
11.1. Market Share Analysis
11.2. Strategies Adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 12 Market Insights
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
Chapter 13 Appendix
13.1 List of Tables
13.2 List of Figures
